Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Celecoxib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Medulloblastoma 2 Ependymoma 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pinealoma 1 Peutz-Jeghers Syndrome 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Gemcitabine 48 pembrolizumab 40 Cisplatin 37 Magnetic Resonance Spectroscopy 23 Specimen Handling 21 Cystectomy 19 Nivolumab 18 enfortumab vedotin 15 durvalumab 15 Carboplatin 14 atezolizumab 13 avelumab 12 Docetaxel 12 Cystoscopy 12 Mitomycin 10 Radiation 8 Paclitaxel 8 Ipilimumab 8 Fluorouracil 8 sacituzumab govitecan 7 Radiotherapy 7 Transurethral Resection of Bladder 6 Standard of Care 6 Platinum 6 Immunoglobulin G 6 Disulfides 6 1,2-diaminocyclohexaneplatinum II citrate 6 erdafitinib 5 cemiplimab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02885974 2025-07-28

BLAST

Baylor College of Medicine

Phase 1 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡